Stem Cell Reviews and Reports

, Volume 7, Issue 4, pp 958–968 | Cite as

Variation in Mesodermal and Hematopoietic Potential of Adult Skin-derived Induced Pluripotent Stem Cell Lines in Mice

  • Tomoko Inoue
  • Kasem Kulkeaw
  • Satoko Okayama
  • Kenzaburo Tani
  • Daisuke SugiyamaEmail author


Induced pluripotent stem cells (iPSCs) are a promising tool for regenerative medicine. Use of iPSC lines for future hematotherapy will require examination of their hematopoietic potential. Adult skin fibroblast somatic cells constitute a source of iPSCs that can be accessed clinically without ethical issues. Here, we used different methods to compare mesodermal and hematopoietic potential by embryoid body formation of five iPSC lines established from adult mouse tail-tip fibroblasts (TTFs). We observed variation in proliferation and in expression of genes (Brachyury, Tbx1, Gata1, Klf1, Csf1r) and proteins (Flk1, Ter119 and CD45) among TTF-derived lines. 256H18 iPSCs showed highest proliferation and most efficient differentiation into mesodermal and hematopoietic cells, while expression levels of the pluripotency genes Oct3/4, Sox2, Klf4 and Nanog were lowest among lines analyzed. By contrast, the 212B2 line, transduced with c-Myc, showed lowest proliferation and differentiation potential, although expression levels of Oct3/4, Sox2 and Klf4 were highest. Overall, we find that mesodermal and hematopoietic potential varies among iPSCs from an identical tissue source and that c-Myc expression likely underlies these differences.


Induced pluripotent stem cells Tail-tip fibroblasts Embryoid body Mesodermal induction Hematopoietic potential 



This work was supported by a grant from the Project for Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology and by a grant from the BASIS project from the Ministry of Education, Culture, Sports, Science and Technology. T. Inoue and K. Kulkeaw is supported by research fellowships from the Ministry of Education, Culture, Sports, Science and Technology, and from The Tokyo Biochemical Research Foundation, respectively. We thank Dr. Keisuke Okita, Ms. Yuka Horio, Ms. Chiyo Mizuochi and the Research Support Center, Graduate School of Medical Sciences, Kyushu University for technical supports, and Dr. Minetaro Ogawa and Dr. Hiroshi Sakamoto for providing LIF. All iPSCs were kindly provided by Dr. Shinya Yamanaka.

Author Contributions

Tomoko Inoue performed the experiments, analyzed data and wrote the manuscript. Kasem Kulkeaw, Satoko Okayama and Kenzaburo Tani performed the experiments. Daisuke Sugiyama designed the experiments and wrote the manuscript.

Conflict of Interest

All disclosures will be published when the manuscript is accepted.

Supplementary material

12015_2011_9249_Fig5_ESM.jpg (577 kb)
Supplementary Fig. 1a

(JPEG 577 kb)

12015_2011_9249_Fig6_ESM.jpg (497 kb)
Supplementary Fig. 1b

(JPEG 496 kb)

12015_2011_9249_Fig7_ESM.jpg (376 kb)
Supplementary Fig. 2

(JPEG 376 kb)

12015_2011_9249_Fig8_ESM.jpg (625 kb)
Supplementary Fig. 3

(JPEG 624 kb)

12015_2011_9249_Fig9_ESM.jpg (387 kb)
Supplementary Fig. 4a,b

(JPEG 387 kb)

12015_2011_9249_Fig10_ESM.jpg (373 kb)
Supplementary Fig. 4c

(JPEG 372 kb)

12015_2011_9249_Fig11_ESM.jpg (445 kb)
Supplementary Fig. 5

(JPEG 445 kb)


  1. 1.
    Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.PubMedCrossRefGoogle Scholar
  2. 2.
    Wernig, M., Meissner, A., Foreman, R., et al. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 448, 318–324.PubMedCrossRefGoogle Scholar
  3. 3.
    Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature, 448, 313–317.PubMedCrossRefGoogle Scholar
  4. 4.
    Yu, J., Vodyanik, M. A., Smuga-Otto, K., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917–1920.PubMedCrossRefGoogle Scholar
  5. 5.
    Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Mael, A. A., Terzic, A., & Ikeda, Y. (2009). Induced pluripotent reprogramming from promiscuous human stemness related factors. Clinical and Translational Science, 2, 118–126.PubMedCrossRefGoogle Scholar
  6. 6.
    Nakagawa, M., Koyanagi, M., Tanabe, K., et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnology, 26, 101–106.PubMedCrossRefGoogle Scholar
  7. 7.
    Stadtfeld, M., Brennand, K., & Hochedlinger, K. (2008). Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Current Biology, 18, 890–894.PubMedCrossRefGoogle Scholar
  8. 8.
    Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322, 949–953.PubMedCrossRefGoogle Scholar
  9. 9.
    Aoi, T., Yae, K., Nakagawa, M., et al. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 321, 699–702.PubMedCrossRefGoogle Scholar
  10. 10.
    Hanna, J., Markoulaki, S., Schorderet, P., et al. (2008). Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell, 133, 250–264.PubMedCrossRefGoogle Scholar
  11. 11.
    Takenaka, C., Nishishita, N., Takada, N., Jakt, L. M., & Kawamata, S. (2010). Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Experimental Hematology, 38, 154–162.PubMedCrossRefGoogle Scholar
  12. 12.
    Kulkeaw, K., Horio, Y., Mizuochi, C., Ogawa, M., & Sugiyama, D. (2010). Variation in hematopoietic potential of induced pluripotent stem cell lines. Stem Cell Reviews, 6, 381–389.PubMedCrossRefGoogle Scholar
  13. 13.
    Huber, T. L., Kouskoff, V., Fehling, H. J., Palis, J., & Keller, G. (2004). Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature, 432, 625–630.PubMedCrossRefGoogle Scholar
  14. 14.
    Lengerke, C., Grauer, M., Niebuhr, N. I., et al. (2009). Hematopoietic development from human induced pluripotent stem cells. Annals of the New York Academy of Sciences, 1176, 219–227.PubMedCrossRefGoogle Scholar
  15. 15.
    Era, T., Izumi, N., Hayashi, M., Tada, S., & Nishikawa, S. (2008). Multiple mesoderm subsets give rise to endothelial cells, whereas hematopoietic cells are differentiated only from a restricted subset in embryonic stem cell differentiation culture. Stem Cells, 26, 401–411.PubMedCrossRefGoogle Scholar
  16. 16.
    Kataoka, H., Takakura, N., Nishikawa, S., et al. (1997). Expressions of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells. Development, Growth & Differentiation, 39, 729–740.CrossRefGoogle Scholar
  17. 17.
    Sakurai, H., Era, T., Jakt, L. M., Okada, M., Nakai, S., & Nishikawa, S. (2006). In vitro modeling of paraxial and lateral mesoderm differentiation reveals early reversibility. Stem Cells, 24, 575–586.PubMedCrossRefGoogle Scholar
  18. 18.
    Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C., & Keller, G. (1998). A common precursor for hematopoietic and endothelial cells. Development, 125, 725–732.PubMedGoogle Scholar
  19. 19.
    Fehling, H. J., Lacaud, G., Kubo, A., et al. (2003). Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development, 130, 4217–4227.PubMedCrossRefGoogle Scholar
  20. 20.
    Chapman, D. L., Agulnik, I., Hancock, S., Silver, L. M., & Papaioannou, V. E. (1996). Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. Developmental Biology, 180, 534–542.PubMedCrossRefGoogle Scholar
  21. 21.
    Wilkinson, D. G., Bhatt, S., & Herrmann, B. G. (1990). Expression pattern of the mouse T gene and its role in mesoderm formation. Nature, 343, 657–659.PubMedCrossRefGoogle Scholar
  22. 22.
    Whitelaw, E., Tsai, S. F., Hogben, P., & Orkin, S. H. (1990). Regulated expression of globin chains and the erythroid transcription factor GATA-1 during erythropoiesis in the developing mouse. Molecular and Cellular Biology, 10, 6596–6606.PubMedGoogle Scholar
  23. 23.
    Miller, I. J., & Bieker, J. J. (1993). A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Molecular and Cellular Biology, 13, 2776–2786.PubMedGoogle Scholar
  24. 24.
    Varlakhanova, N. V., Cotterman, R. F., & deVries, W. N. (2010). Myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation, 80, 9–19.PubMedCrossRefGoogle Scholar
  25. 25.
    Smith, K. N., Singh, A. M., & Dalton, S. (2010). Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell, 7, 343–54.PubMedCrossRefGoogle Scholar
  26. 26.
    Martinez-Fernandez, A., Nelson, T. J., Ikeda, Y., & Terzic, A. (2010). c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells. Journal of Cardiovascular Translational Research, 3, 13–23.PubMedCrossRefGoogle Scholar
  27. 27.
    Polo, J. M., Liu, S., & Figueroa, M. E. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnology, 28, 848–55.PubMedCrossRefGoogle Scholar
  28. 28.
    Loh, Y. H., Agarwal, S., & Park, I. H. (2009). Generation of induced pluripotent stem cells from human blood. Blood, 113, 5476–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Tomoko Inoue
    • 1
    • 2
  • Kasem Kulkeaw
    • 1
  • Satoko Okayama
    • 1
  • Kenzaburo Tani
    • 2
  • Daisuke Sugiyama
    • 1
    Email author
  1. 1.Department of Hematopoietic Stem Cells, SSP Stem Cell UnitKyushu University Faculty of Medical SciencesFukuokaJapan
  2. 2.Department of Molecular Genetics, Medical Institute of BioregulationKyushu UniversityFukuokaJapan

Personalised recommendations